These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36204241)

  • 1. Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension.
    Lawrie A; Hamilton N; Wood S; Exposto F; Muzwidzwa R; Raiteri L; Beaudet A; Muller A; Sauter R; Pillai N; Kiely DG
    Pulm Circ; 2022 Oct; 12(4):e12136. PubMed ID: 36204241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertension.
    Lawrie A; Hamilton N; Wood S; Exposto F; Muzwidzwa R; Raiteri L; Beaudet A; Muller A; Sauter R; Pillai N; Kiely DG;
    Pulm Circ; 2024 Jul; 14(3):e12399. PubMed ID: 38979095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
    Kiely DG; Hamilton N; Wood S; Durrington C; Exposto F; Muzwidzwa R; Raiteri L; Beaudet A; Muller A; Sauter R; Pillai N; Lawrie A;
    BMJ Open; 2024 Jan; 14(1):e080068. PubMed ID: 38176861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
    Hu T; Miles AC; Pond T; Boikos C; Maleki F; Alfred T; Lopez SMC; McGrath L
    J Med Econ; 2024; 27(1):324-336. PubMed ID: 38343288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
    Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States.
    Scott A; Chambers R; Reimbaeva M; Atwell J; Baillon-Plot N; Draica F; Tarallo M
    J Med Econ; 2022; 25(1):287-298. PubMed ID: 35114896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
    Parikh KS; Dahhan T; Nicholl L; Ruopp N; Pomann GM; Fortin T; Tapson VF; Rajagopal S
    Sci Rep; 2019 Mar; 9(1):4061. PubMed ID: 30858405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis.
    Weiss T; Near AM; Zhao X; Ramey DR; Banerji T; Xie H; Nathan SD
    BMC Pulm Med; 2023 Nov; 23(1):455. PubMed ID: 37990203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
    Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.
    Heerlein K; De Giorgi S; Degraeve G; Frodl T; Hagedoorn W; Oliveira-Maia AJ; Otte C; Perez Sola V; Rathod S; Rosso G; Sierra P; Vita A; Morrens J; Rive B; Mulhern Haughey S; Kambarov Y; Young AH
    J Affect Disord; 2022 Feb; 298(Pt A):442-450. PubMed ID: 34742998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension.
    Abston E; Moll M; Hon S; Govender P; Berman J; Farber H
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):184-191. PubMed ID: 33093782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis.
    Weiss T; Ramey DR; Pham N; Shaikh NF; Tian D; Zhao X; Near AM; Lautsch D; Nathan SD
    Pulm Circ; 2024 Apr; 14(2):e12390. PubMed ID: 38903484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.
    Exposto F; Hermans R; Nordgren Å; Taylor L; Sikander Rehman S; Ogley R; Davies E; Yesufu-Udechuku A; Beaudet A
    Ther Adv Respir Dis; 2021; 15():1753466621995040. PubMed ID: 33620026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
    Heresi G; Dean B; Wu B; Lee H; Sketch MR; Stafkey-Mailey D; Morland K; Classi P; Spikes L
    BMC Pulm Med; 2024 Jul; 24(1):335. PubMed ID: 38992626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
    Toro W; Yang M; Georgieva M; Song W; Patel A; Jiang AX; Zhao A; LaMarca N; Dabbous O
    Adv Ther; 2023 Oct; 40(10):4589-4605. PubMed ID: 37587305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of moderate-to-high-suicide-intent in major depressive disorder: a retrospective cohort study on patient characteristics and healthcare resource utilisation in England.
    Denee T; Kerr C; Richards S; Dennis N; Foix-Colonier A; Fischer C; Larkin F
    BMC Psychiatry; 2024 Aug; 24(1):576. PubMed ID: 39180055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.